Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was involved in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It also focuses on the commercialization of technologies in various industrial sectors. The company is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does Med BioGene Inc (MBGNF) operate in?
Med BioGene Inc belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Med BioGene Inc (MBGNF) current stock price?
As of the latest data, Med BioGene Inc stock price is $0.01, with a previous close of $0.01.
What is Med BioGene Inc (MBGNF) current market capitalization?
Med BioGene Inc market cap is approximately 101.82 thousand.
What is Med BioGene Inc (MBGNF) EBITDA?
Med BioGene Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -18.43 thousand.
Does Med BioGene Inc (MBGNF) pay dividends?
No. Med BioGene Inc does not pay a dividend.
What is Med BioGene Inc (MBGNF) beta (volatility) score?
Med BioGene Inc has a beta of 1.480, suggesting it is more volatile than the market.